It's the end of AMC and I'm about to have a sizeable holding in ChemoSeed. Would rather learn and understand about this pharmaceutical investment than look backward
Читать полностью…Have created a separate Telegram Group to discuss the new company if people are interested.
Читать полностью…I found the response on where has all the money gone unconvincing. RY seemed nervous and muddled answering this question. Also don't know why they need five sets of lawyers to complete an RTO or why administration would take 12 months if the RTO fails. I am treating this as a write-off going forward. An unsatisfactory epilogue to a very unsatisfactory investment experience.
Читать полностью…Couldn't really expect anything different from RY. The constant delay on completing the TEO meant that we missed the boat on selling the asset for fair value. The promised RTO or distribution of remaining cash also overshot the conveyed timing and now we are left with Hobsons choice. Although I don't support the choice of investment at least it kicks RY off the gravy train and for that reason only I will vote in support.
Читать полностью…I’m leaving this group now it’s gone to crism, it’s been a pleasure everyone, until next time!
Читать полностью…Fair enough. Onwards and upwards hopefully. Best of luck to everyone - who knows maybe this could be the golden ticket AMC had the promise to be
Читать полностью…Amur Minerals Corp - Result of AGM and GM #AMC @amur_minerals https://www.voxmarkets.co.uk/rns/announcement/407a5b26-a5b8-46a9-9e98-7f9c7cf21248 #voxmarkets undefined
Читать полностью…The board of Amur Minerals Corp has announced a reorganisation of the company's share capital. Shareholders as at close of business on 30 May 2024 will have their holding consolidated, receiving 1 new share in place of every 160 previously held. The new consolidated shares are expected on or around 31 May 2024. Please note we will credit the shares to your account upon receipt from the registrar which may not be before 8.00am on 31 May 2024.
The company is also proposing to change its name to Crism Therapeutics Corporation.
The proposals are subject to shareholder approval at an general meeting (GM) on 29 May 2024.